Table 2

Clinical characteristics of the subgroup of patients who underwent polysomnography*

WHO group IWHO group IIWHO group IIIWHO group IVP†
Number of patients (N=83)3730115
Demographics
Age, years57 (46–69)65 (54–74)68 (54–73)55 (49–56)0.03
Male gender8 (22%)8 (27%)6 (55%)3 (60%)0.08
Body mass index, kg/m230 (26–33)35 (29–40)26 (25–33)30 (29–31)0.06
Chronic medical conditions
Connective tissue disease22 (59%)4 (13%)3 (27%)0 (0%)<0.01
Chronic obstructive pulmonary disease5 (14%)1 (3%)5 (45%)0 (0%)<0.01
Interstitial lung disease9 (24%)2 (7%)6 (55%)0 (0%)<0.01
Right heart catheterisation
MPAP, mm Hg34 (27–44)43 (33–54)31 (28–40)37 (37–42)0.14
PAOP, mm Hg11 (9–13)19 (17–26)12 (9–14)14 (11–14)<0.01
PVR, wood units3.3 (2.4–7.4)3.5 (2.5–7.4)4.8 (3.2–5.8)4.3 (4.0–6.1)0.84
Sleep study
 Total sleep time, minutes317.3 (251.8–348.4)327.3 (242.0–377.4)302.9 (238.2–350.5)363.0 (274.0–382.3)0.90
 Time with SpO2<90%, %8.6 (0.1–41.0)14.0 (3.1–39.4)4.6 (0.4–39.3)98.8 (90.7–99.6)<0.01
 AHI≥513 (35%)27 (90%)4 (36%)5 (100%)<0.01
 5≤AHI < 158 (22%)10 (33%)4 (36%)3 (60%)0.29
 15≤AHI < 301 (3%)8 (27%)0 (0%)0 (0%)<0.01
 AHI≥304 (11%)9 (30%)0 (0%)2 (40%)0.04
 AHI, events per hour2.5 (0.9–8.6)22.5 (6.2–32.1)3.7 (2.1–8.2)10.6 (10.0–31.7)<0.01
 Obstructive apnoeas0 (0–5)6 (0–33)2 (0–8)5 (0–13)0.13
 Central apnoeas0 (0–1)0 (0–3)1 (0–9)4 (0–5)0.18
 Mixed apnoeas0 (0–1)0 (0–2)0 (0–0)0 (0–1)0.77
 Hypopnoeas7 (3–26)63 (36–100)3 (1–34)64 (51–162)<0.01
  • *Data are summarised as median (IQR) for continuous variables and N (%) for categorical variables.

  • †P values are caclulated using the Kruskal-Wallis test for continuous variables and the Χ2 test for categorical variables. P<0.05 was considered statistically significant. P-values <0.05 are indicated in boldface.

  • AHI, apnoea-hypopnea index; MPAP, mean pulmonary artery pressure; PAOP, pulmonary artery occlusion pressure; PVR, pulmonary vascular resistance.